 |
Falchi Lorenzo; Nijland Marcel; Huang Huiqiang; Linton Kim M; Seymour John F; Tao Rong; Kwiatek Michal; Costa Abel; Vassilakopoulos Theodoros P; Greil Richard; Jiménez-Ubieto Ana; Gangatharan Shane A; Benjamini Ohad; Thieblemont Catherine; Tucci Alessandra; Elinder-Camburn Anna; Illes Arpad; Novak Jan; Pavlovsky Miguel A; McDonald Andrew; Yoon Dok Hyun; Maruyama Dai; Sunkersett Gauri; Mei Jian P; Mukherjee Nabanita; Zhu Feng; Alshreef Abualbishr; Favaro Elena; Morschhauser Franck; Kollaborációs szervezet: EPCORE FL-1 Investigators; Modok Szabolcs; Mikala Gábor; Masszi András; Rajnics Péter; et al.:
Epcoritamab, lenalidomide, and rituximab versus lenalidomide and rituximab for relapsed or refractory follicular lymphoma (EPCORE FL-1) : a global, open-label, randomised, phase 3 trial.
LANCET, 407 (10524).
pp. 161-173.
ISSN 0140-6736
(2026)
Haslbauer Ferdinand; Petzer Andreas; Safanda Martin; Tomova Antoaneta; Porubska Miriam; Bajory Zoltán; Niepel Daniela; Jaeger Christine; Bjorklof Katja; Kalinin Dmitry; Greil Richard:
Prospective observational study to evaluate the persistence of treatment with denosumab in patients with bone metastases from solid tumors in routine clinical practice: final analysis.
SUPPORTIVE CARE IN CANCER, 28.
pp. 1855-1865.
ISSN 0941-4355
(2020)
![[Fel]](/style/images/multi_up.png)
Vissza
